CUSABIO) New Platform HTP Recombinant Antibody Production to Accelerate the Discovery of Therapeuti
ÀÛ¼ºÀÚ
abbabio
ÀÛ¼ºÀÏÀÚ
2021-10-21
Á¶È¸¼ö
318
If you are unable to see the message below, click here to view.
At present, antibody drugs has become a hot topic in the field of antibody therapeutics. To __select the "right" therapeutic antibodies in a short period of time, high throughput (HTP) recombinant antibody production platform is welcomed by pharmaceutical companies. The technology not only enables the rapid production of large numbers of recombinant antibodies, but also accelerates the discovery of early therapeutic targets.
With over 13 years of experience in antibody production, CUSABIO has supplied tens of thousands of high quality antibodies for life science research. CUSABIO has now established the High Throughput (HTP) Recombinant Antibody Production Platform, which was designed to help researchers gain rapid access to promising recombinant antibodies, thereby accelerating the process of initial drug screens. The platform is dedicated to pharmaceutical companies and enables them to pick out the "right" therapeutic antibodies in a short time with very competitive quotation. Let's get to know it better!
► HTP Recombinant Antibody Production Services Overview
► Services Details
Service Name
Service Description
Deliverables
Timeline
Price (USD)
HTP (high throughput) Recombinant Antibody Production
Rapid production for a number of recombinant antibodies at various scale in HEK293 cell;
Starts with either codon optimization and gene synthesis;
Affinity purified antibody (up to mg level) from 30 mL cell culture supernatant;
Purified antibody (SDS-PAGE>95%, endotoxin level <1EU/mg, including SEC-HPLC detection);
As the COVID-19 pandemic evolves, we are with you during these turbulent times. CUSABIO appreciates the critical role that you and our products play in research efforts to further scientific innovation and discovery. We know that many scientists are diligently pursuing their research throughout the pandemic. Our customer service and technical support teams are equipped to remain available to help with your research needs and answer any questions.